Which Prenatal Testing Method Is Non-Invasive? Understanding cfDNA Testing
Learn about cfDNA, a non-invasive prenatal test that screens for fetal chromosomal conditions via a simple maternal blood draw from 10 weeks onward.
275 views
Cell-free fetal DNA testing (cfDNA) is a non-invasive prenatal testing method. Conducted through a simple blood draw from the mother, cfDNA screens for potential chromosomal conditions in the fetus, such as Down syndrome, Edwards syndrome, and Patau syndrome. Being non-invasive, it poses no risk to the fetus. This test is typically offered from 10 weeks of pregnancy onwards and can be an important early step in prenatal care for expecting mothers.
FAQs & Answers
- What is non-invasive prenatal testing (NIPT)? Non-invasive prenatal testing (NIPT) is a screening method that analyzes fetal DNA circulating in the mother's blood to detect chromosomal abnormalities without any risk to the fetus.
- When can cfDNA testing be performed during pregnancy? cfDNA testing is typically offered from 10 weeks of pregnancy onwards, allowing early detection of potential chromosomal conditions.
- Which chromosomal conditions can cfDNA testing screen for? cfDNA testing screens for common chromosomal conditions such as Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13).